Amniotic fluid-derived stem cells as a cell source for bone tissue engineering

Tissue Engineering - Part A

Volumn 18, Issue 23-24, 2012, Pages 2518-2527

  Rodrigues, Márcia T ^a,b   Lee, Sang Jin ^a   Gomes, Manuela E ^b   Reis, Rui L ^b   Atala, Anthony ^a   Yoo, James J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BONE TISSUE; BONE TISSUE ENGINEERING; CAPROLACTONE; CELL SOURCES; EXPRESSION PATTERNS; GOLD STANDARDS; HUMAN CELLS; MARROW-DERIVED STEM CELLS; MICROFIBROUS; MINERALIZED EXTRACELLULAR MATRIXES; OSTEOGENIC; OSTEOGENIC CELLS; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC PHENOTYPE; OSTEOGENIC POTENTIAL; SIGNIFICANT IMPACTS; STARCH AND POLYCAPROLACTONES; THREE DIMENSIONS; TISSUE CULTURE PLATES; UNIQUE FEATURES;

BONE; CYTOLOGY; STEM CELLS; TISSUE; TISSUE CULTURE;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; ALPL PROTEIN, HUMAN; CALCIUM; POLYCAPROLACTONE; POLYESTER; RUNX2 PROTEIN, HUMAN; SCLEROPROTEIN; STARCH; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR RUNX2;

AMNION FLUID; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; BONE MINERALIZATION; CELL SEPARATION; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INSTRUMENTATION; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; STEM CELL; TIME; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; AMNIOTIC FLUID; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL CULTURE TECHNIQUES; CELL SEPARATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; ORGAN SPECIFICITY; OSTEOGENESIS; POLYESTERS; STARCH; STEM CELLS; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84869750731     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0672     Document Type: Article

References (44)

1. Bajada, S., Mazakova, I., Richardson, J.B., and Ashammakhi, N. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2, 169, 2008.
2. De Coppi, P., Bartsch, G., Jr., Siddiqui, M.M., Xu, T., Santos, C.C., Perin, L., Mostoslavsky, G., Serre, A.C., Snyder, E.Y., Yoo, J.J., Furth, M.E., Soker, S., and Atala, A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25, 100, 2007.
3. Peng, L., Jia, Z., Yin, X., Zhang, X., Liu, Y., Chen, P., Ma, K., and Zhou, C. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev 17, 761, 2008.
4. Ringe, J., Leinhase, I., Stich, S., Loch, A., Neumann, K., Haisch, A., Haupl, T., Manz, R., Kaps, C., and Sittinger, M. Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. J Tissue Eng Regen Med 2, 136, 2008.
5. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
6. Fauza, D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18, 877, 2004.
7. Krampera, M., Pizzolo, G., Aprili, G., and Franchini, M. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone 39, 678, 2006.
8. Mauney, J.R., Volloch, V., and Kaplan, D.L. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11, 787, 2005.
9. Tuan, R.S., Boland, G., and Tuli, R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5, 32, 2003.
10. Kretlow, J.D., Jin, Y.Q., Liu, W., Zhang, W.J., Hong, T.H., Zhou, G., Baggett, L.S., Mikos, A.G., and Cao, Y. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 9, 60, 2008.
11. Stolzing, A., Jones, E., McGonagle, D., and Scutt, A. Agerelated changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129, 163, 2008.
12. Poloni, A., Maurizi, G., Babini, L., Serrani, F., Berardinelli, E., Mancini, S., Costantini, B., Discepoli, G., and Leoni, P. Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion. Cell Transplant 20, 643, 2011.
13. Rosland, G.V., Svendsen, A., Torsvik, A., Sobala, E., McCormack, E., Immervoll, H., Mysliwietz, J., Tonn, J.C., Goldbrunner, R., Lonning, P.E., Bjerkvig, R., and Schichor, C. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69, 5331, 2009.
14. Pirraco, R.P., Obokata, H., Iwata, T., Marques, A.P., Tsuneda, S., Yamato, M., Reis, R.L., and Okano, T. Development of osteogenic cell sheets for bone tissue engineering applications. Tissue Eng Part A 17, 1507, 2011.
15. Mathews, S., Mathew, S.A., Gupta, P.K., Bhonde, R., and Totey, S. Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchymal stem cells. J Tissue Eng Regen Med 2012 [Epub ahead of print]; DOI: 10.1002/term.1507.
16. Vishnubalaji, R., Al-Nbaheen, M., Kadalmani, B., Aldahmash, A., and Ramesh, T. Comparative investigation of the differentiation capability of bone-marrow- and adiposederived mesenchymal stem cells by qualitative and quantitative analysis. Cell Tissue Res 347, 419, 2012.
17. Kuroda, R., Ishida, K., Matsumoto, T., Akisue, T., Fujioka, H., Mizuno, K., Ohgushi, H., Wakitani, S., and Kurosaka, M. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 15, 226, 2007.
18. Wakitani, S., Mitsuoka, T., Nakamura, N., Toritsuka, Y., Nakamura, Y., and Horibe, S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13, 595, 2004.
19. Kumar, S., Wan, C., Ramaswamy, G., Clemens, T.L., and Ponnazhagan, S. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther 18, 1026, 2010.
20. Prusa, A.R., Marton, E., Rosner, M., Bernaschek, G., and Hengstschlager, M. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18, 1489, 2003.
21. Rodrigues, M.T., Lee, S.J., Gomes, M.E., Reis, R.L., Atala, A., and Yoo, J.J. Bilayered constructs aimed at osteochondral strategies: the influence of medium supplements in the osteogenic and chondrogenic differentiation of amniotic fluidderived stem cells. Acta Biomater 8, 2795, 2012.
22. Nadri, S., and Soleimani, M. Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. Cytotherapy 9, 729, 2007.
23. Sessarego, N., Parodi, A., Podesta, M., Benvenuto, F., Mogni, M., Raviolo, V., Lituania, M., Kunkl, A., Ferlazzo, G., Bricarelli, F.D., Uccelli, A., and Frassoni, F. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 93, 339, 2008.
24. Discher, D.E., Mooney, D.J., and Zandstra, P.W. Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673, 2009.
25. Khatiwala, C.B., Kim, P.D., Peyton, S.R., and Putnam, A.J. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK. J Bone Miner Res 24, 886, 2009.
26. Navarro, M., Michiardi, A., Castano, O., and Planell, J.A. Biomaterials in orthopaedics. J R Soc Interface 5, 1137, 2008.
27. Dado, D., and Levenberg, S. Cell-scaffold mechanical interplay within engineered tissue. Semin Cell Dev Biol 20, 656, 2009.
28. Stevens, M.M., and George, J.H. Exploring and engineering the cell surface interface. Science 310, 1135, 2005.
29. Kolambkar, Y.M., Peister, A., Ekaputra, A.K., Hutmacher, D.W., and Guldberg, R.E. Colonization and osteogenic differentiation of different stem cell sources on electrospun nanofiber meshes. Tissue Eng Part A 16, 3219, 2010.
30. Sun, H., Feng, K., Hu, J., Soker, S., Atala, A., and Ma, P.X. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 31, 1133, 2010.
31. Peister, A., Woodruff, M.A., Prince, J.J., Gray, D.P., Hutmacher, D.W., and Guldberg, R.E. Cell sourcing for bone tissue engineering: amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. Stem Cell Res 7, 17, 2011.
32. Gomes, M.E., Azevedo, H.S., Moreira, A.R., Ella, V., Kellomaki, M., and Reis, R.L. Starch-poly(epsilon-caprolactone) and starch-poly(lactic acid) fibre-mesh scaffolds for bone tissue engineering applications: structure, mechanical properties and degradation behaviour. J Tissue Eng Regen Med 2, 243, 2008.
33. Gomes, M.E., Bossano, C.M., Johnston, C.M., Reis, R.L., and Mikos, A.G. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng 12, 177, 2006.
34. Gomes, M.E., Holtorf, H.L., Reis, R.L., and Mikos, A.G. Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng 12, 801, 2006.
35. Rodrigues, M.T., Gomes, M.E., Viegas, C.A., Azevedo, J.T., Dias, I.R., Guzón, F., and Reis, R.L. Tissue engineered constructs based on SPCL scaffolds cultured with goat marrow cells: functionality in femoral defects. J Tissue Eng Regen Med 5, 41, 2011.
36. Santos, M.I., Fuchs, S., Gomes, M.E., Unger, R.E., Reis, R.L., and Kirkpatrick, C.J. Response of micro- and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering. Biomaterials 28, 240, 2007.
37. Gu, L.S., Kim, J., Kim, Y.K., Liu, Y., Dickens, S.H., Pashley, D.H., Ling, J.Q., and Tay, F.R. A chemical phosphorylationinspired design for type I collagen biomimetic remineralization. Dent Mater 26, 1077, 2010.
38. Davies, J.E. In vitro modeling of the bone/implant interface. Anat Rec 245, 426, 1996.
39. Choi, C.K., Breckenridge, M.T., and Chen, C.S. Engineered materials and the cellular microenvironment: a strengthening interface between cell biology and bioengineering. Trends Cell Biol 20, 705, 2010.
40. Park, J.Y., Takayama, S., and Lee, S.H. Regulating microenvironmental stimuli for stem cells and cancer cells using microsystems. Integr Biol (Camb) 2, 229, 2010.
41. Tonnarelli, B., Manferdini, C., Piacentini, A., Codeluppi, K., Zini, N., Ghisu, S., Facchini, A., and Lisignoli, G. Surfacedependent modulation of proliferation, bone matrix molecules, and inflammatory factors in human osteoblasts. J Biomed Mater Res A 89, 687, 2009.
42. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
43. Tsai, M.S., Hwang, S.M., Chen, K.D., Lee, Y.S., Hsu, L.W., Chang, Y.J., Wang, C.N., Peng, H.H., Chang, Y.L., Chao, A.S., Chang, S.D., Lee, K.D., Wang, T.H., Wang, H.S., and Soong, Y.K. Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 25, 2511, 2007.
44. Miranda-Sayago, J.M., Fernandez-Arcas, N., Benito, C., Reyes-Engel, A., Carrera, J., and Alonso, A. Lifespan of human amniotic fluid-derived multipotent mesenchymal stromal cells. Cytotherapy 13, 572, 2011.